These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3474078)

  • 1. Tissue levels of ofloxacin in the urogenital system.
    di Silverio F; Cruciani E; Ferrone G; de Marco F; Lauretti S; Prencipe MG
    Chemioterapia; 1987 Apr; 6(2):120-3. PubMed ID: 3474078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diffusion of ofloxacin (OFLX) into prostatic tissue in patients with benign prostatic hypertrophy].
    Uchibayashi T; Nagano K; Shoda R; Hisazumi H; Sawaki M; Yamaguchi K; Kawaguchi K; Komatsu K; Kobashi K; Koizumi H
    Hinyokika Kiyo; 1990 Jun; 36(6):741-5. PubMed ID: 1700587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ofloxacin concentration in human prostatic tissue after 3 days of administration].
    Morita M; Hasuda A
    Hinyokika Kiyo; 1989 Jan; 35(1):187-90. PubMed ID: 2729016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Concentration of cefoperazone in various tissues of the urogenital system (author's transl)].
    Schalkhäuser K; Adam D
    Arzneimittelforschung; 1981; 31(10):1770-2. PubMed ID: 6459099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration into human urogenital tissues, muscle tissues, rib and cerebrospinal fluid of thiamphenicol.
    Plomp TA; Schalkhäuser KM; Maes RA
    Arzneimittelforschung; 1981; 31(7):1165-8. PubMed ID: 7196767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-bacterial effect of ofloxacin--in vitro and in vivo results].
    Altay G; Tulunay C
    Mikrobiyol Bul; 1985 Oct; 19(4):183-9. PubMed ID: 3868736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity and concentrations in serum, urine, prostatic secretion and adenoma tissue of ofloxacin in urological patients.
    Naber KG; Adam D; Kees F
    Drugs; 1987; 34 Suppl 1():44-50. PubMed ID: 3481328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ofloxacin concentration in human benign prostatic tissue after oral administration.
    Asakawa M; Yasumoto R
    Hinyokika Kiyo; 1988 Jun; 34(6):1097-9. PubMed ID: 2464915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prostatic tissue levels of ceftizoxime].
    Hoshi S; Kimura M; Kuwahara M; Orikasa S; Nakano S; Chiba R; Ishii N; Kato M; Morita M; Kato H
    Hinyokika Kiyo; 1985 May; 31(5):863-70. PubMed ID: 3901702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacokinetics of ofloxacin in the elderly (65-85 years) with normal renal function after a single oral dose of 200 mg].
    Veyssier P; Fourtillan JB; Modai J; Couet W; Lefebvre MA; Darchis JP; Vincent Du Laurier M; Bryskier A
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):596-9. PubMed ID: 3534750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ofloxacin therapy of difficult-to-treat infections due to multiresistant organisms.
    el-Baz W; Osman L; Abd-el-Hamid T; el-Bokl M; Sabbour MS
    Chemioterapia; 1987 Apr; 6(2):129-33. PubMed ID: 3474079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose linearity and other pharmacokinetics of ofloxacin: a new, broad-spectrum antimicrobial agent.
    Verho M; Malerczyk V; Dagrosa E; Korn A
    Pharmatherapeutica; 1985; 4(6):376-82. PubMed ID: 3866256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prostatic tissue and fluid levels of DL-8280].
    Kumon H; Furukawa M; Mizuno A; Miyata K; Akazawa N; Ohmori H; Katayama Y; Akaeda T
    Hinyokika Kiyo; 1984 Sep; 30(9):1297-305. PubMed ID: 6596879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibacterial activity of ofloxacin in urine for 4 days after a single oral dose of 400 mg].
    Guibert J; Kitzis MD; Acar JF
    Pathol Biol (Paris); 1998 Oct; 46(8):656-60. PubMed ID: 9871938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Laboratory and clinical study of ofloxacin in the treatment of bacterial prostatitis].
    Suzuki K; Tamai H; Naide Y; Ando K; Moriguchi R
    Hinyokika Kiyo; 1984 Oct; 30(10):1505-18. PubMed ID: 6596877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue concentrations of ofloxacin in the middle ear.
    Thorn V
    Clin Ther; 1987; 9(5):523-7. PubMed ID: 3478138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ofloxacin concentration in prostatic tissue].
    Kawauchi A; Kamoi K; Ohne T; Imada N; Kitamori T; Terasaki T; Watanabe H
    Hinyokika Kiyo; 1993 Dec; 39(12):1191-3. PubMed ID: 7506868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary pharmacokinetic and clinical evaluation of ofloxacin in dental and oral cavity diseases.
    Pappalardo G; Bianchi A; Scire Scappuzzo G; Mirone M; Salomone S
    Int J Clin Pharmacol Res; 1989; 9(3):229-32. PubMed ID: 2663738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro activity, serum, urine and prostatic adenoma concentrations of ofloxacin in urologic patients with complicated urinary tract infections].
    Naber KG; Adam D; Wittenberger R; Bartosik-Wich B
    Infection; 1986; 14 Suppl 1():S60-4. PubMed ID: 2420725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multicenter study of ofloxacin activity on bacteria isolated from a hospital environment].
    Soussy CJ; Le Van Thoi J; Duval J; Morel C; Malbruny B; Acar JF; Kitzis MD; Mounier M; Denis F; Courvalin P
    Pathol Biol (Paris); 1986 May; 34(5):390-8. PubMed ID: 3534711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.